Finance entity
All 1 tracked stories fall under one category: markets. Exelixis is most often covered alongside Inari Medical, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.4 in the same window.
Last mentioned: Mar 14, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Exelixis is most often covered alongside Inari Medical, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.4 in the same window. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline. We currently track 1 Finance story that mention Exelixis, all published on March 14, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 95 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Exelixis. Shared-story counts are live from our verified record — not editorial picks.
Following the conclusion of the latest earnings season, quantitative analysis reveals a surge in mid-cap healthcare and communication services stocks. Leading the pack are companies like Inari Medical and Ziff Davis, which have demonstrated superior profitability and growth metrics relative to their peers.
Exelixis is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
